Experimental Drug for Alzheimer Disease Shows Promise
After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques
Only registered members have full access to PracticeUpdate content.